http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2655492-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b74452a889073845b47a40e23c273814
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
filingDate 2011-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1d263b145a08f7177f1446b57a6007e
publicationDate 2018-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2655492-T3
titleOfInvention Formulations comprising methylthioninium chloride
abstract A pharmaceutical composition in a solid dosage form which is a tablet comprising, as an active ingredient, methylthioninium chloride (MTC), said composition additionally comprising at least one diluent suitable for direct compression which is microcrystalline cellulose or a sugar, in the that the MTC exists in a substantially pure and stable polymorphic form, which is the Form A polymorph in which the amount of MTC in the composition is more than 10% w / w, and in which the composition is obtained by a process comprising dry compression of a mixture of intimate powders of the MTC in a substantially pure polymorphic form with the at least one diluent suitable for direct compression and, optionally, one or more other excipients.
priorityDate 2010-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378884
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476681
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13853

Total number of triples: 35.